Journal article
Antithrombotic Therapy for Atrial Fibrillation Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
Abstract
BACKGROUND: The risk of stroke varies considerably across different groups of patients with atrial fibrillation (AF). Antithrombotic prophylaxis for stroke is associated with an increased risk of bleeding. We provide recommendations for antithrombotic treatment based on net clinical benefit for patients with AF at varying levels of stroke risk and in a number of common clinical scenarios.
METHODS: We used the methods described in the …
Authors
You JJ; Singer DE; Howard PA; Lane DA; Eckman MH; Fang MC; Hylek EM; Schulman S; Go AS; Hughes M
Journal
CHEST Journal, Vol. 141, No. 2, pp. e531s–e575s
Publisher
Elsevier
Publication Date
February 2012
DOI
10.1378/chest.11-2304
ISSN
0012-3692
Associated Experts
Fields of Research (FoR)
Medical Subject Headings (MeSH)
Administration, OralAnticoagulantsAspirinAtrial FibrillationAtrial FlutterBenzimidazolesClopidogrelDabigatranDose-Response Relationship, DrugDrug Therapy, CombinationElectric CountershockEvidence-Based MedicineFibrinolytic AgentsHemorrhageHumansInternational Normalized RatioRisk FactorsSocieties, MedicalStrokeTiclopidineVitamin Kbeta-Alanine